Showing results (51-60 of 157) with videos related to
Sort By:
Pageof 16
Neurourology and Urodynamics|September 30, 2009
Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptomsKenneth M Peters, Kim A Killinger, Brian M Boguslawski, et al.The Journal of Sexual Medicine|March 1, 2013
Changes in sexual functioning in women after neuromodulation for voiding dysfunctionJessica M Yih, Kim A Killinger, Judith A Boura, et al.Current Urology Reports|July 2, 2013
Understanding clinic options for overactive bladderJamie M Bartley, Emily S Blum, Larry T Sirls, et al.Neurourology and Urodynamics|July 1, 2021
Initial experience using a novel nerve stimulator for the management of pudendal neuralgiaLy Hoang Roberts, Annah Vollstedt, Joshua Volin, et al.The Journal of Urology|April 17, 2012
Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitisPradeep Tyagi, Kim Killinger, Vikas Tyagi, et al.Advances in Therapy|May 15, 2024
Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable DevicesUna J Lee, Scott MacDiarmid, Catherine A Matthews, et al.Urology|March 30, 2013
Clinical outcomes of sacral neuromodulation in patients with neurologic conditionsKenneth M Peters, Pridvi Kandagatla, Kim A Killinger, et al.Urology|October 1, 2013
Cystectomy for ulcerative interstitial cystitis: sequelae and patients' perceptions of improvementKenneth M Peters, Christopher Jaeger, Kim A Killinger, et al.Neurourology and Urodynamics|July 21, 2021
Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesionsRobert Evans, Alfred Kohan, Robert Moldwin, et al.Lower Urinary Tract Symptoms|December 15, 2015
Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome PatientsKenneth M Peters, Nirmal Jayabalan, Don Bui, et al.Pageof 16